{"product_id":"new-product-581591","title":"ApoE Monoclonal Antibody","description":"\u003cp\u003eThe protein encoded by this gene is a major apoprotein of the chylomicron. It binds to a specific liver and peripheral cell receptor, and is essential for the normal catabolism of triglyceride-rich lipoprotein constituents. This gene maps to chromosome 19 in a cluster with the related apolipoprotein C1 and C2 genes. Mutations in this gene result in familial dysbetalipoproteinemia, or type III hyperlipoproteinemia (HLP III), in which increased plasma cholesterol and triglycerides are the consequence of impaired clearance of chylomicron and VLDL remnants.\u003c\/p\u003e\n\u003cp\u003eIntroducing the APOE Monoclonal Antibody, a cutting-edge pharmaceutical innovation designed to target and neutralize the Apolipoprotein E (APOE) protein. This meticulously developed antibody showcases exceptional specificity and affinity towards APOE, offering a promising solution for various medical applications.\u003cbr\u003e\u003cbr\u003eCrafted with utmost precision, the APOE Monoclonal Antibody exhibits remarkable efficacy in inhibiting the pathological effects associated with APOE dysregulation. By selectively binding to APOE, this antibody effectively hinders its detrimental actions, thereby presenting a potential therapeutic avenue for a multitude of disorders.\u003cbr\u003e\u003cbr\u003eThe APOE Monoclonal Antibody's exceptional specificity ensures minimal off-target effects, guaranteeing a high degree of safety and reliability. Its robust binding affinity enables efficient neutralization of APOE, thereby mitigating the detrimental consequences associated with its aberrant expression.\u003cbr\u003e\u003cbr\u003eThis groundbreaking pharmaceutical asset holds immense promise in the field of neurodegenerative diseases, where APOE has been implicated in the pathogenesis of conditions such as Alzheimer's disease. By effectively targeting APOE, this antibody offers a potential avenue for therapeutic intervention, aiming to alleviate the burden of these debilitating disorders.\u003cbr\u003e\u003cbr\u003eFurthermore, the APOE Monoclonal Antibody's versatility extends beyond neurodegenerative diseases, as it holds potential in various other medical domains. Its ability to modulate APOE expression and function opens doors for novel therapeutic strategies in cardiovascular diseases, metabolic disorders, and even certain cancers.\u003cbr\u003e\u003cbr\u003eIn conclusion, the APOE Monoclonal Antibody represents a remarkable advancement in the realm of pharmaceutical innovation. With its exceptional specificity, robust binding affinity, and potential therapeutic applications in various medical fields, this antibody holds immense promise for the future of targeted therapy. Embrace the power of precision medicine with the APOE Monoclonal Antibody, and unlock new possibilities in the realm of personalized healthcare.\u003c\/p\u003e","brand":"BT Lab","offers":[{"title":"100ul \/ Mouse \/ Primary antibody","offer_id":47548564504856,"sku":"BT-MCA0172","price":300.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0590\/5652\/1400\/products\/BT_Lab_86733b6a-66bf-43ea-92bb-1fe8462c52a8.png?v=1705696388","url":"https:\/\/danabiosci.com\/products\/new-product-581591","provider":"Dana Bioscience","version":"1.0","type":"link"}